Araştırma Makalesi

Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital

Cilt: 11 Sayı: 1 14 Mart 2026
PDF İndir
TR EN

Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital

Öz

Introduction and Objective: Vaginitis is a common gynecological condition, and its true prevalence varies due to factors such as a high proportion of asymptomatic cases, self-diagnosis, and treatment errors. This study was designed as a descriptive, cross-sectional study aimed at retrospectively evaluating the prevalence of vaginitis among female patients aged 18 years and older who presented to a Training and Research Hospital with complaints of vaginitis. Methods: Data on patients’ demographic characteristics, time of presentation (day, month, and hour), and the number of patients by year were retrospectively reviewed using a computer-based patient registration system. Results: The average age of the patients was found to be 34.64±8.86. When examining the years of examination, it was found that 35.5% of the patients were examined in 2019, 18.8% in 2020, 21% in 2021, and 24.6% in 2022. It was observed that a smear test was recommended for 4.9% of the patients, and their average age was 39.88±7.14. It was found that an HPV test was requested for 0.8% of the patients, with an average age of 40.27±6.45 years. Conclusion: The study determined that the frequent cases of vaginitis in the 18-49 age range were consistent with the literature. The prevalence and causes of vaginal infections are multifaceted. Since it is a significant public health issue commonly seen in women and, if left untreated, can lead to chronic conditions, infertility, and cancer, there is a need to increase studies in the literature evaluating the prevalence of vaginitis.

Anahtar Kelimeler

Destekleyen Kurum

Kırklareli University

Etik Beyan

Before starting the research, the necessary permissions were obtained from the Ethics Committee of the Institute of Health Sciences at Kırklareli University (Protocol No: PR0448R01, Decision No: 2, Decision Date: 20.03.2023) and from the Kırklareli Provincial Health Directorate (Decision No: 16, Decision Date: 01.06.2023).

Teşekkür

We thank the Kırklareli Provincial Health Directorate for their support in conducting the research.

Kaynakça

  1. Holdcroft AM, Ireland DJ, Payne MS. The vaginal microbiome in health and disease: what role do common intimate hygiene practices play? Microorganisms. 2023;11(2):298.
  2. Chang AW. Vaginitis. In: Chang AW, editor. Common cases in women’s primary care clinics. Cham: Springer International Publishing; 2024. p. 61–70.
  3. Huang SH, Hsu HC, Lee TF, Fan HM, Tseng CW, Chen IH, et al. Prevalence, associated factors, and appropriateness of empirical treatment of trichomoniasis, bacterial vaginosis, and vulvovaginal candidiasis among women with vaginitis. Microbiol Spectr. 2023;11(3):e00161-23.
  4. Zhou YX, Wang L, Wang TT, Qu XL, Zhang XQ. Analysis of HPV prevalence among individuals with reproductive tract infections in a Chinese population. Medicine (Baltimore). 2023;102(41):e34989.
  5. Bignoumba M, Mbombe Moghoa KH, Muandze-Nzambe JU, Kassa Kassa RF, Mouanga Ndzime Y, Gafou A, et al. Vaginal infections’ etiologies in south-eastern Gabon: an overview. Int J Womens Health. 2022;14:505 515.
  6. Pan Z, Wu Y, Li Y, Hu X, Zhao Y, Liu Y. Retrospective study of pathogens involved in vaginitis among Chinese women. BMC Womens Health. 2023;23(1):364.
  7. Mujuzi H, Siya A, Wambi R. Infectious vaginitis among women seeking reproductive health services at a sexual and reproductive health facility in Kampala, Uganda. BMC Womens Health. 2023;23(1):677.
  8. Czeisler MÉ. Delay or avoidance of medical care because of COVID-19–related concerns— United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1250–1257.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Tıbbi Enfeksiyon Ajanları

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

14 Mart 2026

Gönderilme Tarihi

30 Ocak 2026

Kabul Tarihi

5 Mart 2026

Yayımlandığı Sayı

Yıl 2026 Cilt: 11 Sayı: 1

Kaynak Göster

APA
Tabaksoy, H., & Hacıoğlu, Ö. (2026). Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital. Journal of Immunology and Clinical Microbiology, 11(1), 39-44. https://doi.org/10.58854/jicm.1878325
AMA
1.Tabaksoy H, Hacıoğlu Ö. Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital. J Immunol Clin Microbiol. 2026;11(1):39-44. doi:10.58854/jicm.1878325
Chicago
Tabaksoy, Hilal, ve Özgenur Hacıoğlu. 2026. “Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital”. Journal of Immunology and Clinical Microbiology 11 (1): 39-44. https://doi.org/10.58854/jicm.1878325.
EndNote
Tabaksoy H, Hacıoğlu Ö (01 Mart 2026) Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital. Journal of Immunology and Clinical Microbiology 11 1 39–44.
IEEE
[1]H. Tabaksoy ve Ö. Hacıoğlu, “Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital”, J Immunol Clin Microbiol, c. 11, sy 1, ss. 39–44, Mar. 2026, doi: 10.58854/jicm.1878325.
ISNAD
Tabaksoy, Hilal - Hacıoğlu, Özgenur. “Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital”. Journal of Immunology and Clinical Microbiology 11/1 (01 Mart 2026): 39-44. https://doi.org/10.58854/jicm.1878325.
JAMA
1.Tabaksoy H, Hacıoğlu Ö. Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital. J Immunol Clin Microbiol. 2026;11:39–44.
MLA
Tabaksoy, Hilal, ve Özgenur Hacıoğlu. “Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital”. Journal of Immunology and Clinical Microbiology, c. 11, sy 1, Mart 2026, ss. 39-44, doi:10.58854/jicm.1878325.
Vancouver
1.Hilal Tabaksoy, Özgenur Hacıoğlu. Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital. J Immunol Clin Microbiol. 01 Mart 2026;11(1):39-44. doi:10.58854/jicm.1878325

88x31.png 

Creative Commons Attribution Non-Commercial License: The articles in the Journal of Immunology and Clinical Microbiology are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

JICM bir QMEL® Tıp & Yayınevi ürünüdür.